|
0
|
|
Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals.
(nature.com)
|
Liedes O
…
Melin M
Nature Microbiology
2026-01-01
|
#infection
#vaccination
#influenza
#immunity
#antibody
|
|
0
|
|
Lessons from the European mpox outbreak: strengthening cohort research for future pandemic preparedness.
(linkinghub.elsevier.com)
|
Visentin A
…
Tacconelli E
Clinical Microbiology and Infection
2026-01-01
|
#infection
#vaccination
#epidemiology
#cohort
#pandemic
|
|
0
|
|
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial.
(linkinghub.elsevier.com)
|
Wang S
…
Chen Z
Clinical Microbiology and Infection
2026-01-01
|
#vaccination
#clinical trial
#herpes zoster
#efficacy
|
|
0
|
|
Elebsiran and PEG-IFNalpha for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.
(nature.com)
|
Wong GL
…
Hong Z
Nature Medicine
2026-01-01
|
#vaccination
#immunity
#rnai
#hepatitis b
#interferon
|
|
0
|
|
Localized Outbreak of Macrolide-Resistant Pertussis in Infants, Japan, March-May 2025.
(wwwnc.cdc.gov)
|
Obara T
…
Hirai K
Emerging Infectious Diseases
2026-01-01
|
#infection
#amr
#vaccination
#pertussis
|
|
0
|
|
Efficacy of influenza vaccines and its relationship with immunological surrogate endpoints: a systematic review and meta-analysis of randomized controlled trial.
(linkinghub.elsevier.com)
|
Cao H
…
Feng D
Clinical Microbiology and Infection
2026-01-01
|
#vaccination
#influenza
#meta-analysis
#immunogenicity
#efficacy
|
|
0
|
|
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.
(linkinghub.elsevier.com)
|
Hall VG
…
Ferreira VH
Clinical Microbiology and Infection
2026-01-01
|
#infection
#vaccination
#transplantation
#immunogenicity
#immunocompromised
|
|
0
|
|
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies.
(linkinghub.elsevier.com)
|
Danysz M
…
Willicombe M
Clinical Microbiology and Infection
2026-01-01
|
#infection
#vaccination
#meta-analysis
#immunity
#immunogenicity
|
|
0
|
|
Reduced Emergency Department Visits and Hospitalizations in Infants after Universal Respiratory Syncytial Virus Immunization, Italy, 2024-25.
(wwwnc.cdc.gov)
|
Villa S
…
Cereda D
Emerging Infectious Diseases
2026-01-01
|
#infection
#vaccination
#rsv
|
|
0
|
|
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.
(nature.com)
|
Kapulu MC
…
Bejon P
Nature Medicine
2026-01-01
|
#infection
#vaccination
#immunity
#malaria
|
|
0
|
|
A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice.
(nature.com)
|
Shi D
…
Tolia NH
Nature Microbiology
2026-01-01
|
#nanoparticles
#vaccination
#immunity
#malaria
#antigen
|
|
0
|
|
Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial.
(linkinghub.elsevier.com)
|
Agnandji ST
…
Mordmuller B
Lancet Infectious Diseases
2026-01-01
|
#vaccination
#malaria
#clinical trial
#immunology
|
|
0
|
|
Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in Sao Paulo, Brazil: a test-negative, case-control study.
(linkinghub.elsevier.com)
|
Ranzani OT
…
Croda J
Lancet Infectious Diseases
2026-01-01
|
#infection
#vaccination
#epidemiology
#dengue
|
|
0
|
|
Innovation in active and passive immunisation of people who are immunocompromised: a call to action.
(linkinghub.elsevier.com)
|
Hill JA
…
Halasa N
Lancet Infectious Diseases
2026-01-01
|
#infection
#vaccination
#immunity
#immunocompromised
|